Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. has reported a year-over-year increase of 1.6% in its product and services revenue, surpassing company forecasts due to favorable deal timing. The company's diversified revenue growth, particularly in the Other category driven by innovations like AtmosAuto and Dolby Cinema, positions it for further expansion, especially with nearly half of total licensing revenues coming from these areas. Additionally, Dolby's strategic initiatives, including SaaS-like models for patent licensing and the OptiView solution, are anticipated to enhance revenue streams, reinforcing a positive outlook for the company's financial performance.

Bears say

Dolby Laboratories Inc. is projected to experience a decline in revenue, with expectations of a 7.5% year-over-year decrease in License Revenue and a 5.7% drop in Products and Services for the December quarter. Additionally, gross margins have decreased to 89.8% from 90.8% due to lower margins in Product/Services, further exacerbated by a forecasted high-single-digit revenue decline for fiscal 2026, mirroring the trends observed in fiscal 2025. The company faces challenges in the PC and consumer electronics markets, which are expected to contribute to overall weakening revenue prospects, alongside modestly lower licensing revenues and difficult year-over-year comparisons in the upcoming quarter.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.